Scopus BioPharma Announces Closing of $9 Million Follow-On Public Offering

Retrieved on: 2021-01-30 00:56:15

Tags for this article:

Click the tags to see associated articles and topics

Scopus BioPharma Announces Closing of $9 Million Follow-On Public Offering. View article details on hiswai:

Excerpt

29, 2021 /PRNewswire/ -- Scopus BioPharma Inc. (Nasdaq: "SCPS") today ... Scopus is a biopharmaceutical company developing transformational ...

Article found on: www.biospace.com